Boess Carsten
SEC-identified person · CIK 1277495 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Atrium Therapeutics, Inc. RNA | Director | filed 2026 - 2026 |
| Avidity Biosciences, Inc. RNAM | Director | filed 2020 - 2026 |
| Rocket Pharmaceuticals, INC. RCKT | Director | filed 2016 - 2025 |
| Orchestra Biomed Holdings, Inc. OBIO | Director | filed 2020 - 2020 |
| Kiniksa Pharmaceuticals, Ltd. KNSA | Officer | filed 2018 - 2018 |
| Trimeris INC TRMS | SVP, Chief Financial Officer | filed 2011 - 2015 |
| Insulet Corp PODD | Vice President, International | filed 2007 - 2011 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.